Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials
Crossref DOI link: https://doi.org/10.1007/s40262-018-0726-6
Published Online: 2018-12-04
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qi, Yulan
McKeever, Kathleen
Taylor, Julie
Haller, Christine
Song, Wenjie
Jones, Simon A.
Shi, Jack
Text and Data Mining valid from 2018-12-04
Article History
First Online: 4 December 2018